ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintSite TitleTitle ChevronIcon Twitter
Coronavirus

COVID ICU patient survival rate has improved, study review shows

Intensive care patient mortality drops by about one-third since pandemic started

The death rate for COVID-19 intensive care patients has dropped by about one-third since the start of the pandemic, a review of published studies shows.   © Reuters

The death rate for COVID-19 intensive care patients has dropped by about one-third since the start of the pandemic, due at least in part to better hospital care, a review of published studies found.

The global analysis of 24 observational studies of COVID-19, the disease caused by the novel coronavirus, was published on Wednesday in the journal Anaesthesia.

The research, led by Professor Tim Cook of England's Royal United Hospitals Bath, found the overall mortality rate of COVID-19 patients in intensive care units (ICUs) has fallen from almost 60% since the end of March to 42% at the end of May. The rate was not significantly different across Europe, Asia and North America.

Study authors offered several explanations, including "rapid learning that has taken place on a global scale due to the prompt publication of clinical reports early in the pandemic." They also suggested that hospital ICUs might have been under greater pressure early in the pandemic.

Doctors have reported progress in learning enough about the highly contagious virus to have a better grasp of key problems for many patients, although much work remains to be done on the development of treatments and preventive vaccines.

The researchers said their findings could reflect the time for long ICU stays to show up in the data, noting that nearly a third of UK ICU admissions lasted more than 28 days and 9% lasted more than 42 days.

The authors emphasized that the recent COVID-19 ICU mortality rate of around 40% is still much higher than the 22% for other viral pneumonias.

"Optimistically, as the pandemic progresses, we may be coping better with COVID-19," they said.

(Reuters)

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends July 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media